Crescent Biopharma Cash Flow Statement (2013-2026) | CBIO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-14.27M	-14.40M	-17.33M	-17.42M	-14.65M	-13.27M	-8.52M	-10.24M	-10.36M	-8.26M	-9.20M	-9.08M	-10.74M	-10.10M	-2.63M	-2.34M	-21.79M	-24.61M	-90.40M	-23.28M
Depreciation and Depletion (Quarter)	0.07M	0.07M	0.07M	0.06M	0.06M	0.05M	0.05M	0.05M	0.04M	0.04M	0.04M	0.02M	0.01M				-0.01M		0.05M	0.06M
Share-based Compensation (Quarter)	1.61M	1.56M	1.59M	1.32M	1.08M	0.96M	0.91M	0.90M	0.87M	0.86M	0.89M	0.91M	0.04M	1.21M	0.07M	0.41M			4.75M	4.11M
Gains from Sales and Divestitures (Quarter)			0.19M	0.19M	0.08M	0.11M	0.11M	0.11M	0.07M	0.07M	0.07M	0.07M	0.06M	0.06M	0.06M	0.05M
Gains from Investment Securities (Quarter)	-0.00M	0.02M	0.44M		1.35M	0.58M	0.58M		2.58M	0.00M	2.63M	-0.09M	0.00M	0.09M		8.99M	1.63M			0.01M
Non-cash Items (Quarter)	0.00M	0.01M	3.95M	4.94M	0.03M	0.03M	4.51M	4.45M	4.93M	1.04M	4.83M	4.20M	1.06M	1.18M	8.83M	0.43M
Cash from Operations (Quarter)																				-8.90M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.18M	0.18M	0.19M	0.19M	0.20M	0.20M	0.21M	0.21M	0.22M	0.22M	0.23M	0.19M	0.17M				-0.15M		0.10M	0.10M
Amortization of Deferred Charges (Quarter)	0.18M	0.18M	0.19M
Depreciation & Amortization (CF) (Quarter)	0.07M	0.07M	0.07M	0.06M	0.06M	0.05M	0.05M	0.05M	0.04M	0.04M	0.04M	0.02M	0.01M				-0.01M		0.05M	0.06M
Change in Working Capital
Change in Receivables (Quarter)																				-18.00M
Change in Account Payables (Quarter)																				-2.31M
Change in Accured Expenses (Quarter)																				-3.46M
Other Working Capital Changes (Quarter)																				-0.10M
Investing Activities
Capital Expenditures (Quarter)																				0.15M
Cash from Investing Activities (Quarter)																				-8.15M
Change in Intangibles (Quarter)																				8.00M
Financing Activities
Other financing activities (Quarter)																1.49M
Cash from Financing Activities (Quarter)																				-6.95M
Additional items
Change in Cash (Quarter)																				-24.03M
Free Cash Flow (Quarter)																				-9.05M
Net Cash Flow (Quarter)																				-23.99M

Research Tools

Crescent Biopharma Cash Flow Statement (2013-2026) | CBIO

Create an account

Sign In

Reset Password